The effect of rosiglitazone on the serum intercellular adhesion molecule-1(ICAM-1) levels of diabetic rats
YE Shan-donga
Abstract
YE Shan-donga
Abstract
Objective To observe the effect of rosiglitazone on the serum intercellular adhesion molecule-1(ICAM-1) levels,and find its possible protective effects on macroangiopathy.Method 24 Wistar rats were randomly assigned to normal control(group A) group,diabetic group(group B) and rosiglitazone treatment(group C) group.Rats in Group C were treated with rosiglitazone(5 mg·kg-1·d-1)one week after the establishment of diabetic model,group A and B were treated with corresponding sodium chloride.Blood glucose was testsd weekly,serum ICAM-1 level was tested by ELISA at the 8th week.Result At the 2nd,4th and 8th week,blood glucose levels in group B were similar to those of group C,which were much higher than those of group A(P0.01).serum ICAM-1 levels in group B and group C were higher than that of group A(P0.01),and serum ICAM-1 level in group C was lower than that of group B(P0.01).Conclusion Rosiglitazone has the effect of antiinflammation,which may play some protection against the progress of atherogenesis in diabetic rats.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of rosiglitazone on the serum intercellular adhesion molecule-1(ICAM-1) levels,and find its possible protective effects on macroangiopathy.Method 24 Wistar rats were randomly assigned to normal control(group A) group,diabetic group(group B) and rosiglitazone treatment(group C) group.Rats in Group C were treated with rosiglitazone(5 mg·kg-1·d-1)one week after the establishment of diabetic model,group A and B were treated with corresponding sodium chloride.Blood glucose was testsd weekly,serum ICAM-1 level was tested by ELISA at the 8th week.Result At the 2nd,4th and 8th week,blood glucose levels in group B were similar to those of group C,which were much higher than those of group A(P0.01).serum ICAM-1 levels in group B and group C were higher than that of group A(P0.01),and serum ICAM-1 level in group C was lower than that of group B(P0.01).Conclusion Rosiglitazone has the effect of antiinflammation,which may play some protection against the progress of atherogenesis in diabetic rats.
Key concepts: Rosiglitazone, Medicine, ICAM-1, Intercellular Adhesion Molecule-1, Internal medicine, Group B, Endocrinology, Diabetes mellitus